Atherosclerosis
Volume 182, Issue 1 , Pages 79-85 , September 2005

Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging

  • Marc Sirol

      Affiliations

    • Department of Cardiology, Hôpital Lariboisière, Paris, France
    • Imaging Science Laboratories. Department of Radiology Mount Sinai School of Medicine, New York, NY, USA
    • The Zena and Michael A. Wiener Cardiovascular Institute, The Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School of Medicine, Box 1030, One Gustave L. Place, New York, NY, USA
    • ,
  • Juan G.S. Aguinaldo

      Affiliations

    • Imaging Science Laboratories. Department of Radiology Mount Sinai School of Medicine, New York, NY, USA
    • The Zena and Michael A. Wiener Cardiovascular Institute, The Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School of Medicine, Box 1030, One Gustave L. Place, New York, NY, USA
    • ,
  • Philip B. Graham

      Affiliations

    • Epix Pharmaceuticals, Cambridge, MA, USA
    • ,
  • Robert Weisskoff

      Affiliations

    • Epix Pharmaceuticals, Cambridge, MA, USA
    • ,
  • Randy Lauffer

      Affiliations

    • Epix Pharmaceuticals, Cambridge, MA, USA
    • ,
  • Gabor Mizsei

      Affiliations

    • Imaging Science Laboratories. Department of Radiology Mount Sinai School of Medicine, New York, NY, USA
    • The Zena and Michael A. Wiener Cardiovascular Institute, The Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School of Medicine, Box 1030, One Gustave L. Place, New York, NY, USA
    • ,
  • Igor Chereshnev

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, The Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School of Medicine, Box 1030, One Gustave L. Place, New York, NY, USA
    • ,
  • John T. Fallon

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, The Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School of Medicine, Box 1030, One Gustave L. Place, New York, NY, USA
    • Department of Pathology, Mount Sinai Medical Center, New York, NY, USA
    • ,
  • Ernane Reis

      Affiliations

    • Department of Surgery, Mount Sinai School of Medicine, New York, NY, USA
    • ,
  • Valentin Fuster

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, The Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School of Medicine, Box 1030, One Gustave L. Place, New York, NY, USA
    • ,
  • Jean-François Toussaint

      Affiliations

    • Department of Radioisotopes, Hôpital Européen Georges Pompidou, Paris, France
    • ,
  • Zahi A. Fayad

      Affiliations

    • Imaging Science Laboratories. Department of Radiology Mount Sinai School of Medicine, New York, NY, USA
    • The Zena and Michael A. Wiener Cardiovascular Institute, The Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School of Medicine, Box 1030, One Gustave L. Place, New York, NY, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 241 6858; fax: +1 212 534 2683.

Received 1 December 2004 ,Revised 28 January 2005 ,Accepted 9 February 2005.

References 

  1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. Parts 1 and 2. N Engl J Med. 1992;326:242–250310-318
  2. Rauch U, Osende JI, Fuster V, et al. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med. 2001;134:224–238
  3. Klein AL, Grimm RA, Murray RD, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001;344:1411–1420
  4. MacNeill BD, Lowe HC, Takano M, Fuster V, Jang I-K. Intravascular modalities for detection of vulnerable plaque: current status. Arterioscler Thromb Vasc Biol. 2003;23:1333–1342
  5. Jaffer FA, Tung C-H, Wykrzykowska JJ, et al. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation. 2004;110:170–176
  6. Bates SM, Lister-James J, Julian JA, et al. Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients with acute deep vein thrombosis or a history of deep vein thrombosis. Arch Intern Med. 2003;163:452–456
  7. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932–938
  8. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res. 2001;89:305–316
  9. Corti R, Osende JI, Fayad ZA, et al. In vivo non-invasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol. 2002;39:1366–1373
  10. Johnstone MT, Botnar RM, Perez AS, et al. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol. 2001;21:1556–1560
  11. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227–1234
  12. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation. 2001;104:1280–1285
  13. Caravan P, Kolodziej A, Greenwood J, et al. EP-1242: a fibrin targeted contrast agent for thrombus imaging. Proc Int Soc Magan Reson Med. 2002;10:1579
  14. Moody AR, Allder S, Lennox G, Gladman J, Fentem P. Direct magnetic resonance imaging of carotid artery thrombus in acute stroke. Lancet. 1999;353:122–123
  15. Marchal G, Bosmans H. Contrast-enhanced magnetic resonance angiography. In:  Thomsen H,  Muller R,  Mattrey R editor. Trends in contrast media. Amsterdam, Netherlands: Springer; 1999;p. 267–283
  16. Botnar RM, Perez AS, Witte S, et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation. 2004;109:2023–2029
  17. Stepnick DW, Hayden RE, Hogikyan ND. Development of thrombosis models in the rabbit. Arch Otolaryngol Head Neck Surg. 1998;120:997–1002
  18. Turitto VT, Hall CL. Mechanical factors affecting hemostasis and thrombosis. Thromb Res. 1998;92:S25–S31
  19. Moody AR, Murphy RE, Morgan PS, et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation. 2003;107:3047–3052
  20. Kramer CM, Cerilli LA, Hagspiel K, et al. Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm. Circulation. 2004;109:1016–1021
  21. Chu B, Kampschulte A, Ferguson MS, et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke. 2004;35:1079–1084
  22. Schmitz SA, Winterhalter S, Schiffler S, et al. USPIO-enhanced direct MR imaging of thrombus: preclinical evaluation in rabbits. Radiology. 2001;221:237–243
  23. Mitchel J, Waters D, Lai T, et al. Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99m DMP-444: a canine model. Circulation. 2000;101:1643–1646
  24. Manca G, Parenti G, Bellina R, et al. 111In platelet scintigraphy for the non-invasive detection of carotid plaque thrombosis. Stroke. 2001;32:719–727
  25. Hamilton AJ, Huang SL, Warnick D, et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol. 2004;43:453–460
  26. Leber AW, Knez A, Becker A, et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J Am College Cardiol. 2004;43:1241–1247
  27. Becker CR, Nikolaou K, Muders M, et al. Ex vivo coronary atherosclerotic plaque characterization with multi-detector-row CT. Eur Radiol. 2003;13:2094–2098
  28. Kniffin WD, Baron JA, Barrett J, Birkmeyer JD, Anderson FA. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med. 1994;154:861–866
  29. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933–938
  30. Ojio S, Takatsu H, Tanaka T, et al. Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within one week before the onset of infarction. Circulation. 2000;102:2063–2069

☆ The work was performed at Mount Sinai School of Medicine, New York, NY, USA.

PII: S0021-9150(05)00124-3

doi: 10.1016/j.atherosclerosis.2005.02.013

Atherosclerosis
Volume 182, Issue 1 , Pages 79-85 , September 2005

Article Tools

* Image Usage & Resolution